Baylor Genetics provides genetic testing and genomic analysis, including whole genome, whole exome and RNA sequencing, as a joint venture of Baylor College of Medicine and HU Group Holdings.
Baylor Genetics is a clinical diagnostics company that provides genetic testing and genomic analysis to healthcare providers and patients worldwide. Formed as a joint venture between Baylor College of Medicine and HU Group Holdings, Inc., the company has performed more than 4 million tests and draws on nearly 50 years of work in genetic testing, including contributions to the development of chromosomal microarray analysis and whole exome sequencing.
Its testing portfolio spans whole genome sequencing, whole exome sequencing, RNA sequencing, chromosomal microarray analysis and a range of specialised assays. The results are interpreted by a team of PhDs, MDs, laboratory directors and genetic counselors, with the stated aim of translating complex genomic data into clinically actionable findings. The work serves areas including rare diseases, pediatric genetics, reproductive health, hereditary cancer and metabolic disorders.
Baylor Genetics operates accredited laboratories: its services are certified under CLIA, accredited by CAP and approved by the New York State Department of Health. The company reports a geographic reach extending worldwide, with its institutional base in the United States.
